Registry update — unassessed
Nicotinamide Riboside and Milk Production in the NICU
Trial registry update: RECRUITING. No results reported in the supplied registry record.
RCTNotable significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 14, 2026 · Discovered: Sep 23, 2026 · Assessed: — · Research update
What it does not prove
- The study report does not provide results; it is unclear whether supplementation affected milk production, milk composition, or maternal outcomes. The feasibility assessment and any safety data are not described. Without effect sizes and statistical analysis, no conclusion about efficacy can be drawn.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- University of California, Davis
- Published
- Sep 14, 2026
Sources
Primary source
- University of California, Davis ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
This study aims to evaluate the feasibility and effects of nicotinamide riboside (NR) supplementation in lactating mothers of infants expected to be hospitalized in the neonatal intensive care unit (NICU) for at least four weeks.
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.